| Disease Info Index | ||||||||||||||||||||||||||
|
|

Multiple Sclerosis – Treatment to Reduce Symptoms and Modify course of Disease
| |||
Text
Reference – Multiple Sclerosis1. Coyle PK. Disease-modifying agents in multiple sclerosis. Ann Indian Acad Neurol. 2009 Oct–Dec; 12(4): 273–282.2. Gasperini C, Ruggieri S, Pozzilli C. Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets. Therapeutics and Clinical Risk Management 2010; (6): 391–399 3. Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR, on behalf of the Fampridine MS-F203 Investigators. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. The Lancet 2009; 373 (9665): 732-8. 4. Calabresi PA. Diagnosis and Management of Multiple Sclerosis. Am Fam Physician. 2004 Nov 15;70(10):1935-1944. 5. Harrison’s Principles of Internal Medicine 17th Edition. Author: Dr. Simi Paknikar Editor: Dr. Shroff Technical:Lingaraj Editor's Note We would welcome your suggestions to improve and further enhance the content and quality of this article. You are welcome to edit, delete or point out language errors in the article.
|
|
|
|
| Share it! |
|
|




|
Posted by:
peanut03
Posted on: 02/18/2013 Are these oral pills for Multiple Sclerosis prescribed by Doctors in India. Would be interested in knowing about Jaipur and Pune
Reply |
Forward
|